RUBY RODRIGUEZ: Open Payments
NPI 1841950672 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 24 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $592 · 2025 $764
Food & beverage: $764
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $316 |
| AstraZeneca Pharmaceuticals LP | 3 | $124 |
| Novo Nordisk Inc | 4 | $100 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| ABBVIE INC. | 2 | $43 |
| SANOFI-AVENTIS U.S. LLC | 2 | $41 |
| Dynavax Technologies Corporation | 2 | $31 |
| Lundbeck LLC | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: KISUNLA, ZEPBOUND, REXULTI, AIRSUPRA, Wegovy, MOUNJARO, VRAYLAR, TZIELD.
Industry payments across TX — which companies pay providers there.
